Trial Profile
Phase II study of neoadjuvant chemotherapy TS-1 [S 1]/CPT-11 [irinotecan] for advanced lower rectal cancers
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Jan 2008 New trial record.